Newron Pharmaceuticals SpA (NWRN) — Long-term Investment Intensity
Newron Pharmaceuticals SpA (NWRN) has a Long-term Investment Intensity of 1.6% as of December 2014. Long-term investments of CHF584.00K represent 1.6% of total assets of CHF37.07 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Newron Pharmaceuticals SpA shareholders equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Newron Pharmaceuticals SpA Long-term Investment Intensity (2013–2014)
This chart shows how Newron Pharmaceuticals SpA's Long-term Investment Intensity has evolved across 2 annual periods from 2013 to 2014. As of December 2014, the intensity stands at 1.6%, reflecting long-term investments of CHF584.00K against total assets of CHF37.07 Million CHF. Also explore balance sheet size of Newron Pharmaceuticals SpA for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Newron Pharmaceuticals SpA (2013–2014)
The table below presents the year-by-year Long-term Investment Intensity for Newron Pharmaceuticals SpA from 2013 to 2014, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Newron Pharmaceuticals SpA market capitalisation.
| Year | LT Investment Intensity | LT Investments (CHF) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2014 | 1.6% | CHF584.00K | CHF37.07 Million | ▼ -1.6 pp |
| 2013 | 3.2% | CHF1.00 Million | CHF31.62 Million | — |